158 related articles for article (PubMed ID: 6296742)
1. Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Flowers CE; Wilborn WH; Hyde BM
Obstet Gynecol; 1983 Feb; 61(2):135-43. PubMed ID: 6296742
[TBL] [Abstract][Full Text] [Related]
2. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Bewtra C; Kable WT; Gallagher JC
J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
[TBL] [Abstract][Full Text] [Related]
3. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
Gelfand MM; Ferenczy A
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
Wilborn WH; Flowers Ce ; Hyde BM
Contracept Deliv Syst; 1983 Jan; 4(1):71-85. PubMed ID: 12264720
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
Luciano AA; Turksoy RN; Carleo J; Hendrix JW
Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
Weinstein L
Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
Gibbons WE; Moyer DL; Lobo RA; Roy S; Mishell DR
Am J Obstet Gynecol; 1986 Feb; 154(2):456-61. PubMed ID: 3004222
[TBL] [Abstract][Full Text] [Related]
9. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
[TBL] [Abstract][Full Text] [Related]
10. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Odmark IS; Jonsson B; Bäckström T
Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
[TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen/progestogen receptors in the endometrium.
Casper RF
Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
[TBL] [Abstract][Full Text] [Related]
12. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
[TBL] [Abstract][Full Text] [Related]
13. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
14. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
15. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens.
Padwick ML; Pryse-Davies J; Whitehead MI
N Engl J Med; 1986 Oct; 315(15):930-4. PubMed ID: 3762595
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cytologic responses of postmenopausal women to estrogen.
Lin TJ; So-Bosita JL; Brar HK; Roblete BV
Obstet Gynecol; 1973 Jan; 41(1):97-107. PubMed ID: 4345382
[No Abstract] [Full Text] [Related]
18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
19. Transdermal progesterone cream as an alternative progestin in hormone therapy.
Leonetti HB; Landes J; Steinberg D; Anasti JN
Altern Ther Health Med; 2005; 11(6):36-8. PubMed ID: 16320858
[TBL] [Abstract][Full Text] [Related]
20. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Clisham PR; de Ziegler D; Lozano K; Judd HL
Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
